Health Library › Procedures › Radioiodine therapy
Procedure
Radioiodine therapy uses swallowed radioactive iodine to destroy overactive or cancerous thyroid cells.
Radioiodine therapy is a treatment using iodine-131, a radioactive form of iodine. You swallow it as a capsule or liquid. Because thyroid cells naturally absorb iodine, most of the radiation is delivered directly to thyroid tissue.
The radiation gradually damages or destroys targeted thyroid cells. It does not produce an immediate result. The effect usually develops over several weeks or months.
Radioiodine can treat an overactive thyroid, also called hyperthyroidism. It may also destroy thyroid cancer cells left after surgery for certain differentiated thyroid cancers, mainly papillary and follicular cancers.
Treatment doses are higher than the small doses used for thyroid scans. A nuclear medicine team plans the amount according to the condition being treated, test results, previous treatment and local safety rules.
For hyperthyroidism, radioiodine reduces the amount of hormone made by an overactive thyroid. It may be offered for Graves disease or for one or more overactive thyroid nodules.
For thyroid cancer, it may be given after surgery to:
Not everyone with thyroid cancer needs radioiodine. Its value is based on the cancer type, tumour features, spread and estimated risk of recurrence.
You may be offered radioiodine if your thyroid remains overactive, if medicines are unsuitable or have not provided lasting control, or if you prefer it to surgery. For thyroid cancer, it is considered when the expected benefit is greater than the possible harm.
Radioiodine is not used during pregnancy because it can damage the developing baby’s thyroid. Pregnancy testing is normally required when pregnancy is possible.
It is also not given while breastfeeding. Breastfeeding must stop before treatment and cannot restart for the current baby because radioactive iodine can collect in breast tissue and breast milk. It may still be possible to breastfeed after a future pregnancy.
Treatment may be avoided, delayed or reconsidered if:
Kidney disease, urinary problems, incontinence or difficulty swallowing can affect planning because radioactive iodine leaves mainly through urine. Tell the team if any of these apply.
Your treating facility’s own instructions take priority because preparation and radiation rules differ by dose, diagnosis and local regulation.
Tell the team about every medicine, vitamin and supplement you take. Iodine supplements, kelp products, some heart medicines, thyroid hormone and antithyroid medicines can affect treatment. Do not stop a prescribed medicine unless your team tells you when and how to do so.
You may be asked to follow a low-iodine diet for a short period. This is not the same as a salt-free diet. The facility should give you a specific food list.
If treatment is for thyroid cancer, your thyroid-stimulating hormone, or TSH, may need to rise so remaining thyroid cells absorb more iodine. This may involve temporarily stopping thyroid hormone or receiving injections of laboratory-made TSH.
You may need to avoid food and drink for several hours around the dose. Tell the team about recent scans using iodine contrast, pregnancy plans and breastfeeding.
Plan for the radiation precautions you will follow afterward. These may include sleeping separately, limiting close contact, avoiding close contact with children and pregnant people, and taking extra care with toilet hygiene. Arrange work, transport and caregiving in advance.
A nuclear medicine professional confirms your identity, treatment plan and safety information. You may have blood tests, a pregnancy test or imaging before the dose.
You swallow the radioiodine as one or more capsules or as a liquid. It has little or no taste. No incision, needle-based anaesthetic or sedation is normally needed.
Swallowing the dose takes only a few minutes. You may then need to wait briefly while the team checks radiation levels and reviews your written precautions.
Most people leave the same day. Higher-dose treatment may require a short hospital stay in a specially prepared room, depending on local regulations and your home circumstances.
Pain: The treatment itself is painless. Some people later develop mild neck tenderness, throat discomfort, nausea or swelling near the salivary glands. Salivary glands make saliva and can also absorb iodine.
Eating: Follow the facility’s instructions about when to eat and drink after the dose. Drinking fluids helps your body remove unused iodine through urine. Ask before using sour sweets or lemon products because advice about their timing is not the same for everyone.
Activity: You can usually do ordinary activities if you feel well. However, radiation precautions temporarily limit close physical contact, shared sleeping arrangements and some social activities. Wash your hands carefully and follow the provided bathroom and laundry instructions.
Driving: Radioiodine does not usually impair alertness because no sedation is used. You can often drive if you feel well, but transport or proximity restrictions may affect the journey home. Follow your facility’s instructions.
Work: Returning to work depends on the dose, travel arrangements and whether your job involves close contact with children, pregnant people or the public. Your team should provide a written date for returning.
An underactive thyroid, called hypothyroidism, commonly develops after successful treatment for Graves disease and can also occur after treatment of overactive nodules. It is treated with thyroid hormone replacement and regular blood tests.
Other possible effects include:
Higher or repeated doses used for thyroid cancer can sometimes affect tear ducts, blood-cell production, fertility or reproductive organs. There is also a small long-term risk of another cancer after substantial cumulative radiation exposure. Your team should explain how these risks apply to the planned treatment.
Radioactive iodine can harm a pregnancy. You and your partner may be told to avoid pregnancy or fathering a pregnancy for a specific period after treatment. Follow the written timeframe given for your treatment.
Radioiodine does not work immediately. For hyperthyroidism, blood tests over the following weeks and months show whether hormone levels are falling. Some people need another treatment or a different option if the first dose does not control the condition.
Long-term blood tests are important because an underactive thyroid may develop months or years later. If it does, daily thyroid hormone usually restores normal hormone levels.
After thyroid cancer treatment, you may have a whole-body scan within days to show where iodine was absorbed. Later follow-up may include thyroglobulin blood tests, neck ultrasound or other imaging. Thyroglobulin is a protein made by thyroid cells and can help monitor some thyroid cancers.
For hyperthyroidism, alternatives include antithyroid medicines and surgery. Antithyroid medicines avoid radiation and can control hormone production, but they require monitoring, may cause side effects and do not always produce lasting remission. Beta blockers like metoprolol or propranolol can ease symptoms such as a racing heartbeat, but they do not treat the overactive thyroid itself.
Surgery removes part or all of the thyroid and works more quickly. It requires anaesthesia and carries risks such as bleeding, low calcium and injury to nerves controlling the voice. It may be preferred for a large thyroid, suspicious nodules, significant compression or certain eye problems.
For selected mild cases, monitoring may be reasonable, but it leaves the thyroid overactive and requires ongoing review.
For thyroid cancer, surgery is usually the main treatment. Some low-risk cancers can be monitored after surgery without radioiodine, avoiding radiation precautions but accepting continued surveillance and some remaining recurrence risk. Carefully selected very small cancers may be monitored without immediate surgery.
Cancers that do not absorb iodine need other approaches. These can include surgery, external-beam radiation, targeted medicines or other systemic treatments. These options have different side effects and are chosen according to where the cancer is and how it behaves.
Contact the nuclear medicine team promptly if you vomit soon after taking the dose. The vomit may contain radioactive material, so do not clean it up until you have received safety instructions.
Call your healthcare team for persistent vomiting, worsening neck swelling, significant salivary gland pain, new eye symptoms or a dry mouth that does not improve. Also arrange routine review if you later notice ongoing tiredness, feeling unusually cold, constipation or other possible signs of an underactive thyroid.
Seek emergency help for trouble breathing, severe difficulty swallowing, fainting, confusion, chest pain, or a very fast or irregular heartbeat with fever or severe agitation.
Will I be asleep?
No. Radioiodine is swallowed while you are awake. Anaesthesia and sedation are not normally needed.
Can I drive home?
Usually, because the treatment does not cause sedation. Your facility may recommend different transport arrangements to limit close contact with other people.
How painful is it?
Swallowing the capsule or liquid is not painful. Mild neck soreness, nausea or salivary gland discomfort can develop later.
When will I know whether it worked?
Hyperthyroidism results become clear through blood tests over weeks to months. Thyroid cancer follow-up may begin with a scan within days, followed by blood tests and imaging over subsequent months.
Will I be radioactive around my family?
You will give off a small amount of radiation for a limited time, and iodine also leaves in urine, saliva and other body fluids. Written precautions reduce other people’s exposure. The duration is based on your dose and household circumstances.
Will my hair fall out?
Radioiodine does not usually cause the widespread hair loss associated with some chemotherapy. Temporary hair thinning can occur when thyroid hormone levels change.
sofidex [Internet]. Daloreum; c2026. Radioiodine therapy; [reviewed 2026 Aug 24; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/procedures/radioiodine-therapy
sofidex. (2026, August 24). Radioiodine therapy. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/procedures/radioiodine-therapy
Radioiodine therapy. sofidex. Reviewed August 24, 2026. Accessed November 10, 2026. https://sofidex.com/patients/procedures/radioiodine-therapy
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.